Fluoroquinolones are well known to have an anti-infective action. In the present study we have described the synthesis of novel florouquinolones derivative as antimicrobial agent. The biological test highlighted a good inhibitory activity for the 7-Chloro-1-Alkyl-6-fluoro-8-nitro-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid derived synthons especially against pathogenic Gram-negative bacteria (Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus and Streptococcus agalactiae). The binding interactions were monitored and could explain the good inhibitory activity of the synthesized derivatives of florouquinolones.
INTROdUCTION
Anti-infective agents played a major role in saving human lives. Among these agents are the fluoroquinolones class, which had risen to be highly appreciated, especially if there was microbial resistance against penicillin and macrolide. Fluoroquinolone pharmacophore (Fig. 1) is well known to have antibacterial activity, and since 1980 there were many generation introduced to the market 1 . The fluoroquinolones were found to be effective to combat urinary tract infection 1 ideal in treating Neisseria gonorrhea 1 and highly effective to treat tuberculosis 2 . In addition, fluoroquinolone nucleus are presented widely in biologically active compounds such as PDE 4 inhibitors 3 , PIM kinase inhibitors 4 , GSK β inhibitors 5 .
Fig. 1. Fluoroquinolone general formula
T h e e n c o u r a g i n g p r o p e r t i e s o f fluoroquinolones such as; broad spectrum of activity, good oral bioavailability, good tissue penetrability and low incidence of adverse effect 6 gave them high appreciation and encouraged researcher to investigate their usefulness as a source of potent antibacterial drugs.
In our previous work, we have described various modifications to the main structure of fluoroquinolone, including the introduction of different substituent's at position 1 and 7 ( Fig. 1 ) and in continuation for obtaining a new fluoroquinolone derivatives with excellent antibacterial activity, our team reported synthon C (1, 2, 3 and 4) as a potent antibacterial agents.
MATERIALS ANd METHOdS

Experimental
Molecular modelling Computational software
The following software packages were utilized: 
Molecular modelling studies
we docked our synthesized molecules using the Dock ligands (libDock) docking alogarithim implemented in the DS 4.5 into the binding pocket of the successful DNA gyraseenzyme namely : (PDB code: 5l3J, resolution 2.83 A).
Chemistry General
All chemicals, reagents and solvents were of analytical/synthetic grade that purchased from Sigma-Aldrich and Acros, Belgium, and used directly without further purification. Nuclear magnetic resonance spectra (NMR) were recorded on Bruker, Avance DPX-300 spectrometer. High-resolution mass spectra (HRMS) were measured in positive or negative ion mode using electrospray ion trap (ESI) technique by collision induced dissociation on a Bruker APEX-4 (7 Tesla) instrument. Melting points were determined in open capillaries on a Stuart scientific electro-thermal melting point apparatus, and are uncorrected. Infra-red (IR) spectra were recorded using Shimadzu 8400F FT-IR spectrophotometer (KBr discs). Microanalyses were performed using EuroVector Elemental Analyser, model (EA3000 A), Jordan University.
Synthesis of synthon (A)
The synthesisof 7-Chloro-1-Alkyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid was previously described by our group 4, 7, 8 . Then adding a substitution at position 7 of (a and b) synthons, was prepared according to reported method 4,8 provided the nitro derivatives synthon C (Scheme 1). The synthesized compounds gave satisfactory analytical and spectroscopic data in accordance with their depicted structures.
Scheme 1. Synthesis of flurouquinolone derivatives
2-[(3-carboxy-1-(4-fluorophenyl)-6-fluoro-8nitro-4-oxo-1,4-dihydroquinolin-7-yl)amino] terephthalic acid (C 1 )
2-Aminoterphthalic acid (3.2 g, 18mmol) was reacted with synthon a (2.0 g, 5.26mmol) and dimethyl sulfoxide (DMSO) 40 ml and pyridine 10ml was heated at 70°C for 10 days under reflux conditions. The mixture was left to cool, then pH was adjusted by 3.5N HCl dried to give the title compound as dark brown solid; Yield ≈ 1. 
2-[(3-Carboxy-1-(4-fluorophenyl)-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinolin-7-yl)amino] phthalic acid (C 2 )
A stirred mixture of 2-Aminophthalic acid (1.6 g, 9mmol), synthon a (1.0 g, 2.63 mmol) and DMSO 20 ml and pyridine 5 ml was heated at 70°C for 10 days under reflux conditions. The same procedure carried out as with synthon C 1 was done and yielded brownish solid compound ; Yield ≈ 0. 
-[ ( 2 -C a r b ox y -1 -p h e ny l e t hy l ) a m i n o ] -1 -(4-fluorophenyl)-6-fluoro-8-nitro-4-oxo-1,4dihydroquinoline-3-carboxylic acid (C 3 )
A stirred mixture of 3-phenyl β-alanine (4.06 g, 24mmol), synthon a(2.0 g, 5.2mmol) and sodium hydrogen carbonate (3.0 g, 36mmol) in 50% aqueous ethanol (280 ml) was heated at 70-80°C for 6 days under reflux condition. The mixture was worked up as described for synthon C 1 . Yellow solid was collected; Yield 2. 
7-(2-Carboxy-ethylamino)-1-(4-chloro-phenyl)-6-fluoro-8-nitro-4-oxo-1,4-dihydro-quinoline-3carboxylic acid.(C 4 )
A mixture of β-alanine (1.05 g, 11.5mmol), Synthon b (1.0 g, 2.2mmol) and sodium hydrogen carbonate (3 g, 35.8mmol) in 50% aqueous ethanol (120 ml) was heated for 6 days under reflux conditions. The product wasworked up as described for synthon C 1 and yielded a yellowish color. 
biological Evaluation Test microorganisms
Six pathogenic bacterial strains were used in the antimicrobial assays, four Grampositive (Staphylococcus aureus ATCC29213, Staphylococcus saprophyticus ATCCRBAA 750, Streptococcus agalactiae ATCC13813,Streptococcus pyogenes ATCC19615, and two Gram-negative (Pseudomonas aeruginosa ATCC27853, Escherichia coli ATCC11775). Those pathogens were chosen based on their clinical and pharmacological importance. Antibacterial activities were evaluated by the agar well diffusion method as recommended by the Clinical and laboratory Standards Institute (ClSI) [9] [10] [11] and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 12-13 .
Measurement of antibacterial activity of the synthetic compounds Preparation of synthetic compounds for microbiological assay
Stock solutions of 20 and 30 mg of each synthetic compound dissolved in 1 ml of dimethyl sulfoxide (DMSO), as solvent. They were sterilized by filtration, and stored at 4 o C. The antimicrobial activity of the synthesized compounds was evaluated by the agar well diffusion method 14 .
determination of antibacterial activity by agar well diffusion method
All the synthetic compounds of different concentrations were screened for their antibacterial activities against the Staphylococcus aureus, Staphylococcus saprophyticus, Streptococcus agalactiae, Streptococcus pyogenes, Pseudomonas aeruginosa and Escherichia coli by agar well diffusion assay. Isolated pure colonies from fresh grown bacteria were transferred from the plates into sterile normal saline solution and vortexed to form bacterial homogenous suspensions. The turbidity was then adjusted to 0.5 McFarland standard units, and a volume of the inoculum was spread on the entire surface of agar. Then, a hole with a diameter of 6-8 mm was punched aseptically using a sterile cork borer, and a volume (20-100 μl) of the synthetic compound was introduced at the desired concentration into the well. Control experiments were carried out under similar conditions using amoxicillin (20 mg), ciprofloxacin (5 mg) and gentamicin (10 mg), as positive controls, and sterile distilled water as negative control. The zones of growth inhibition were measured in millimeters (mm) after 18-24 h of incubation at 37 o C. The sensitivities of the microorganisms to the synthetic compounds were determined by measuring the sizes of inhibitory zones, and values <8 mm were considered as being not active against the tested bacterial strains 15 .
RESULTS ANd dISCUSSION
The synthesized derivatives have been obtained in a good yield, and showed good antibacterial activity against both Gram-positive and Gram-negative bacteria ( Table 1) , and it's well known that position 7 modifications can bring about the major changes in potency. Attachment of aromatic rings having an amino substitution results in improved activity and it also affects the pharmacokinetics of the compound 16 .
The lipophilic substitution at position 1 led to synthons with a good activity against Gram-positive bacteria (Fig. 2) , and position 7 substitution with 2-aminophthalic acid and 3-aminoterphthalic acid imparted both Gram-negative and Gram-positive activity (Figure 2 ). 
CONCLUSION
I n s u m m a r y, w e h a v e e f f i c i e n t l y synthesized a novel series of fluoroquinolonemodified analogues. Biological testing showed that some of the derivatives have good antibacterial activity in a series of primary assays.
